nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Tolmetin—PTGS2—bone cancer	0.00295	1	CrCbGaD
Tolcapone—Dysphagia—Doxorubicin—bone cancer	0.00155	0.00156	CcSEcCtD
Tolcapone—Asthma—Doxorubicin—bone cancer	0.00155	0.00156	CcSEcCtD
Tolcapone—Pollakiuria—Epirubicin—bone cancer	0.00155	0.00155	CcSEcCtD
Tolcapone—Sweating—Methotrexate—bone cancer	0.00153	0.00154	CcSEcCtD
Tolcapone—Feeling abnormal—Cisplatin—bone cancer	0.00153	0.00153	CcSEcCtD
Tolcapone—Haematuria—Methotrexate—bone cancer	0.00152	0.00153	CcSEcCtD
Tolcapone—Weight decreased—Epirubicin—bone cancer	0.00152	0.00152	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—bone cancer	0.00151	0.00152	CcSEcCtD
Tolcapone—Epistaxis—Methotrexate—bone cancer	0.00151	0.00151	CcSEcCtD
Tolcapone—Pneumonia—Epirubicin—bone cancer	0.0015	0.00151	CcSEcCtD
Tolcapone—Infestation—Epirubicin—bone cancer	0.00149	0.0015	CcSEcCtD
Tolcapone—Infestation NOS—Epirubicin—bone cancer	0.00149	0.0015	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—bone cancer	0.00149	0.0015	CcSEcCtD
Tolcapone—Body temperature increased—Cisplatin—bone cancer	0.00147	0.00147	CcSEcCtD
Tolcapone—Neuropathy peripheral—Epirubicin—bone cancer	0.00147	0.00147	CcSEcCtD
Tolcapone—Stomatitis—Epirubicin—bone cancer	0.00146	0.00146	CcSEcCtD
Tolcapone—Urinary tract infection—Epirubicin—bone cancer	0.00145	0.00146	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—bone cancer	0.00145	0.00145	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—bone cancer	0.00144	0.00145	CcSEcCtD
Tolcapone—Haemoglobin—Methotrexate—bone cancer	0.00144	0.00145	CcSEcCtD
Tolcapone—Haemorrhage—Methotrexate—bone cancer	0.00143	0.00144	CcSEcCtD
Tolcapone—Sweating—Epirubicin—bone cancer	0.00143	0.00144	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—bone cancer	0.00143	0.00144	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—bone cancer	0.00143	0.00143	CcSEcCtD
Tolcapone—Pharyngitis—Methotrexate—bone cancer	0.00142	0.00143	CcSEcCtD
Tolcapone—Urinary tract disorder—Methotrexate—bone cancer	0.00142	0.00142	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—bone cancer	0.00141	0.00141	CcSEcCtD
Tolcapone—Urethral disorder—Methotrexate—bone cancer	0.00141	0.00141	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—bone cancer	0.0014	0.00141	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—bone cancer	0.0014	0.00141	CcSEcCtD
Tolcapone—Pneumonia—Doxorubicin—bone cancer	0.00139	0.0014	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—bone cancer	0.00138	0.00139	CcSEcCtD
Tolcapone—Hypersensitivity—Cisplatin—bone cancer	0.00137	0.00137	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—bone cancer	0.00137	0.00137	CcSEcCtD
Tolcapone—Erythema multiforme—Methotrexate—bone cancer	0.00136	0.00136	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—bone cancer	0.00136	0.00136	CcSEcCtD
Tolcapone—Haemoglobin—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—bone cancer	0.00135	0.00135	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—bone cancer	0.00134	0.00135	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—bone cancer	0.00134	0.00135	CcSEcCtD
Tolcapone—Tinnitus—Methotrexate—bone cancer	0.00134	0.00134	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—bone cancer	0.00134	0.00134	CcSEcCtD
Tolcapone—Asthenia—Cisplatin—bone cancer	0.00133	0.00134	CcSEcCtD
Tolcapone—Pharyngitis—Epirubicin—bone cancer	0.00133	0.00134	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—bone cancer	0.00133	0.00133	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—bone cancer	0.00132	0.00133	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—bone cancer	0.00132	0.00132	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—bone cancer	0.0013	0.00131	CcSEcCtD
Tolcapone—Angiopathy—Methotrexate—bone cancer	0.0013	0.0013	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—bone cancer	0.0013	0.0013	CcSEcCtD
Tolcapone—Mediastinal disorder—Methotrexate—bone cancer	0.00129	0.0013	CcSEcCtD
Tolcapone—Chills—Methotrexate—bone cancer	0.00129	0.00129	CcSEcCtD
Tolcapone—Diarrhoea—Cisplatin—bone cancer	0.00127	0.00127	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—bone cancer	0.00127	0.00127	CcSEcCtD
Tolcapone—Alopecia—Methotrexate—bone cancer	0.00127	0.00127	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—bone cancer	0.00126	0.00127	CcSEcCtD
Tolcapone—Mental disorder—Methotrexate—bone cancer	0.00126	0.00126	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—bone cancer	0.00125	0.00125	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—bone cancer	0.00124	0.00125	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—bone cancer	0.00124	0.00125	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—bone cancer	0.00124	0.00124	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—bone cancer	0.00123	0.00124	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—bone cancer	0.00123	0.00123	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—bone cancer	0.00122	0.00123	CcSEcCtD
Tolcapone—Dysgeusia—Methotrexate—bone cancer	0.00122	0.00123	CcSEcCtD
Tolcapone—Angiopathy—Epirubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—bone cancer	0.00122	0.00122	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—bone cancer	0.00121	0.00121	CcSEcCtD
Tolcapone—Chills—Epirubicin—bone cancer	0.0012	0.00121	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—bone cancer	0.0012	0.0012	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—bone cancer	0.00119	0.00119	CcSEcCtD
Tolcapone—Vomiting—Cisplatin—bone cancer	0.00118	0.00118	CcSEcCtD
Tolcapone—Vision blurred—Methotrexate—bone cancer	0.00118	0.00118	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—bone cancer	0.00118	0.00118	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—bone cancer	0.00117	0.00118	CcSEcCtD
Tolcapone—Rash—Cisplatin—bone cancer	0.00117	0.00117	CcSEcCtD
Tolcapone—Dermatitis—Cisplatin—bone cancer	0.00117	0.00117	CcSEcCtD
Tolcapone—Ill-defined disorder—Methotrexate—bone cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—bone cancer	0.00116	0.00116	CcSEcCtD
Tolcapone—Anaemia—Methotrexate—bone cancer	0.00115	0.00116	CcSEcCtD
Tolcapone—Flatulence—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Tolcapone—Tension—Epirubicin—bone cancer	0.00115	0.00115	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—bone cancer	0.00114	0.00115	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—bone cancer	0.00113	0.00114	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—bone cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Malaise—Methotrexate—bone cancer	0.00113	0.00113	CcSEcCtD
Tolcapone—Muscle spasms—Epirubicin—bone cancer	0.00112	0.00113	CcSEcCtD
Tolcapone—Vertigo—Methotrexate—bone cancer	0.00112	0.00112	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—bone cancer	0.00112	0.00112	CcSEcCtD
Tolcapone—Chills—Doxorubicin—bone cancer	0.00111	0.00112	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—bone cancer	0.00111	0.00111	CcSEcCtD
Tolcapone—Nausea—Cisplatin—bone cancer	0.0011	0.00111	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—bone cancer	0.0011	0.0011	CcSEcCtD
Tolcapone—Cough—Methotrexate—bone cancer	0.00109	0.00109	CcSEcCtD
Tolcapone—Mental disorder—Doxorubicin—bone cancer	0.00109	0.00109	CcSEcCtD
Tolcapone—Ill-defined disorder—Epirubicin—bone cancer	0.00108	0.00109	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—bone cancer	0.00108	0.00108	CcSEcCtD
Tolcapone—Agitation—Epirubicin—bone cancer	0.00107	0.00108	CcSEcCtD
Tolcapone—Flatulence—Doxorubicin—bone cancer	0.00107	0.00107	CcSEcCtD
Tolcapone—Myalgia—Methotrexate—bone cancer	0.00106	0.00107	CcSEcCtD
Tolcapone—Chest pain—Methotrexate—bone cancer	0.00106	0.00107	CcSEcCtD
Tolcapone—Arthralgia—Methotrexate—bone cancer	0.00106	0.00107	CcSEcCtD
Tolcapone—Tension—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—bone cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00106	0.00106	CcSEcCtD
Tolcapone—Malaise—Epirubicin—bone cancer	0.00105	0.00106	CcSEcCtD
Tolcapone—Discomfort—Methotrexate—bone cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Nervousness—Doxorubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Syncope—Epirubicin—bone cancer	0.00105	0.00105	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—bone cancer	0.00104	0.00104	CcSEcCtD
Tolcapone—Palpitations—Epirubicin—bone cancer	0.00103	0.00104	CcSEcCtD
Tolcapone—Confusional state—Methotrexate—bone cancer	0.00103	0.00103	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—bone cancer	0.00103	0.00103	CcSEcCtD
Tolcapone—Cough—Epirubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—bone cancer	0.00102	0.00102	CcSEcCtD
Tolcapone—Infection—Methotrexate—bone cancer	0.00101	0.00102	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—bone cancer	0.00101	0.00101	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—bone cancer	0.001	0.00101	CcSEcCtD
Tolcapone—Nervous system disorder—Methotrexate—bone cancer	0.000999	0.001	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—bone cancer	0.000999	0.001	CcSEcCtD
Tolcapone—Thrombocytopenia—Methotrexate—bone cancer	0.000997	0.001	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—bone cancer	0.000995	0.000998	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—bone cancer	0.000995	0.000998	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—bone cancer	0.000995	0.000998	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—bone cancer	0.000993	0.000996	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—bone cancer	0.000991	0.000994	CcSEcCtD
Tolcapone—Skin disorder—Methotrexate—bone cancer	0.00099	0.000993	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000988	0.000991	CcSEcCtD
Tolcapone—Hyperhidrosis—Methotrexate—bone cancer	0.000985	0.000988	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—bone cancer	0.000983	0.000986	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—bone cancer	0.000975	0.000978	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—bone cancer	0.000973	0.000976	CcSEcCtD
Tolcapone—Vertigo—Doxorubicin—bone cancer	0.000971	0.000974	CcSEcCtD
Tolcapone—Anorexia—Methotrexate—bone cancer	0.000971	0.000974	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—bone cancer	0.000969	0.000972	CcSEcCtD
Tolcapone—Confusional state—Epirubicin—bone cancer	0.000961	0.000964	CcSEcCtD
Tolcapone—Palpitations—Doxorubicin—bone cancer	0.000955	0.000958	CcSEcCtD
Tolcapone—Oedema—Epirubicin—bone cancer	0.000953	0.000956	CcSEcCtD
Tolcapone—Hypotension—Methotrexate—bone cancer	0.000952	0.000955	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—bone cancer	0.00095	0.000953	CcSEcCtD
Tolcapone—Infection—Epirubicin—bone cancer	0.000947	0.00095	CcSEcCtD
Tolcapone—Cough—Doxorubicin—bone cancer	0.000943	0.000946	CcSEcCtD
Tolcapone—Shock—Epirubicin—bone cancer	0.000938	0.000941	CcSEcCtD
Tolcapone—Nervous system disorder—Epirubicin—bone cancer	0.000935	0.000938	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—bone cancer	0.000933	0.000936	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—bone cancer	0.000933	0.000936	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—bone cancer	0.000931	0.000933	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000928	0.000931	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—bone cancer	0.000926	0.000929	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—bone cancer	0.000922	0.000924	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—bone cancer	0.00092	0.000923	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—bone cancer	0.00092	0.000923	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—bone cancer	0.00092	0.000923	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—bone cancer	0.000917	0.00092	CcSEcCtD
Tolcapone—Paraesthesia—Methotrexate—bone cancer	0.000915	0.000918	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000914	0.000917	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—bone cancer	0.000909	0.000912	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—bone cancer	0.000909	0.000911	CcSEcCtD
Tolcapone—Dyspnoea—Methotrexate—bone cancer	0.000908	0.000911	CcSEcCtD
Tolcapone—Somnolence—Methotrexate—bone cancer	0.000906	0.000908	CcSEcCtD
Tolcapone—Dry mouth—Doxorubicin—bone cancer	0.0009	0.000903	CcSEcCtD
Tolcapone—Dyspepsia—Methotrexate—bone cancer	0.000897	0.000899	CcSEcCtD
Tolcapone—Hypotension—Epirubicin—bone cancer	0.000891	0.000894	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—bone cancer	0.00089	0.000892	CcSEcCtD
Tolcapone—Decreased appetite—Methotrexate—bone cancer	0.000886	0.000888	CcSEcCtD
Tolcapone—Oedema—Doxorubicin—bone cancer	0.000882	0.000885	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Methotrexate—bone cancer	0.00088	0.000882	CcSEcCtD
Tolcapone—Fatigue—Methotrexate—bone cancer	0.000878	0.000881	CcSEcCtD
Tolcapone—Infection—Doxorubicin—bone cancer	0.000876	0.000879	CcSEcCtD
Tolcapone—Pain—Methotrexate—bone cancer	0.000871	0.000874	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000869	0.000871	CcSEcCtD
Tolcapone—Shock—Doxorubicin—bone cancer	0.000868	0.00087	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—bone cancer	0.000865	0.000868	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—bone cancer	0.000864	0.000866	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—bone cancer	0.000861	0.000864	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—bone cancer	0.000857	0.000859	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—bone cancer	0.000856	0.000859	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—bone cancer	0.000853	0.000855	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—bone cancer	0.00085	0.000853	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—bone cancer	0.000848	0.00085	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—bone cancer	0.000841	0.000843	CcSEcCtD
Tolcapone—Feeling abnormal—Methotrexate—bone cancer	0.00084	0.000842	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—bone cancer	0.000839	0.000842	CcSEcCtD
Tolcapone—Gastrointestinal pain—Methotrexate—bone cancer	0.000833	0.000836	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—bone cancer	0.000829	0.000831	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—bone cancer	0.000824	0.000827	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—bone cancer	0.000823	0.000826	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—bone cancer	0.000822	0.000824	CcSEcCtD
Tolcapone—Pain—Epirubicin—bone cancer	0.000815	0.000818	CcSEcCtD
Tolcapone—Constipation—Epirubicin—bone cancer	0.000815	0.000818	CcSEcCtD
Tolcapone—Urticaria—Methotrexate—bone cancer	0.000809	0.000812	CcSEcCtD
Tolcapone—Body temperature increased—Methotrexate—bone cancer	0.000805	0.000808	CcSEcCtD
Tolcapone—Abdominal pain—Methotrexate—bone cancer	0.000805	0.000808	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000804	0.000806	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—bone cancer	0.000792	0.000794	CcSEcCtD
Tolcapone—Dyspnoea—Doxorubicin—bone cancer	0.000786	0.000789	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—bone cancer	0.000786	0.000788	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—bone cancer	0.000784	0.000787	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—bone cancer	0.00078	0.000782	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—bone cancer	0.000777	0.000779	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—bone cancer	0.000767	0.000769	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000762	0.000764	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—bone cancer	0.000761	0.000763	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—bone cancer	0.000757	0.00076	CcSEcCtD
Tolcapone—Pain—Doxorubicin—bone cancer	0.000754	0.000757	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—bone cancer	0.000754	0.000757	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—bone cancer	0.000754	0.000756	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—bone cancer	0.000754	0.000756	CcSEcCtD
Tolcapone—Hypersensitivity—Methotrexate—bone cancer	0.000751	0.000753	CcSEcCtD
Tolcapone—Asthenia—Methotrexate—bone cancer	0.000731	0.000733	CcSEcCtD
Tolcapone—Feeling abnormal—Doxorubicin—bone cancer	0.000727	0.000729	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—bone cancer	0.000721	0.000724	CcSEcCtD
Tolcapone—Pruritus—Methotrexate—bone cancer	0.000721	0.000723	CcSEcCtD
Tolcapone—Hypersensitivity—Epirubicin—bone cancer	0.000702	0.000705	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—bone cancer	0.000701	0.000703	CcSEcCtD
Tolcapone—Body temperature increased—Doxorubicin—bone cancer	0.000697	0.000699	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—bone cancer	0.000697	0.000699	CcSEcCtD
Tolcapone—Diarrhoea—Methotrexate—bone cancer	0.000697	0.000699	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—bone cancer	0.000684	0.000686	CcSEcCtD
Tolcapone—Pruritus—Epirubicin—bone cancer	0.000675	0.000677	CcSEcCtD
Tolcapone—Dizziness—Methotrexate—bone cancer	0.000674	0.000676	CcSEcCtD
Tolcapone—Diarrhoea—Epirubicin—bone cancer	0.000652	0.000654	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—bone cancer	0.00065	0.000652	CcSEcCtD
Tolcapone—Vomiting—Methotrexate—bone cancer	0.000648	0.00065	CcSEcCtD
Tolcapone—Rash—Methotrexate—bone cancer	0.000642	0.000644	CcSEcCtD
Tolcapone—Dermatitis—Methotrexate—bone cancer	0.000642	0.000644	CcSEcCtD
Tolcapone—Headache—Methotrexate—bone cancer	0.000638	0.00064	CcSEcCtD
Tolcapone—Asthenia—Doxorubicin—bone cancer	0.000633	0.000635	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—bone cancer	0.00063	0.000632	CcSEcCtD
Tolcapone—Pruritus—Doxorubicin—bone cancer	0.000624	0.000626	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—bone cancer	0.000606	0.000608	CcSEcCtD
Tolcapone—Nausea—Methotrexate—bone cancer	0.000605	0.000607	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—bone cancer	0.000604	0.000605	CcSEcCtD
Tolcapone—Rash—Epirubicin—bone cancer	0.000601	0.000603	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—bone cancer	0.000601	0.000602	CcSEcCtD
Tolcapone—Headache—Epirubicin—bone cancer	0.000597	0.000599	CcSEcCtD
Tolcapone—Dizziness—Doxorubicin—bone cancer	0.000583	0.000585	CcSEcCtD
Tolcapone—Nausea—Epirubicin—bone cancer	0.000566	0.000568	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—bone cancer	0.000561	0.000563	CcSEcCtD
Tolcapone—Rash—Doxorubicin—bone cancer	0.000556	0.000558	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—bone cancer	0.000556	0.000557	CcSEcCtD
Tolcapone—Headache—Doxorubicin—bone cancer	0.000553	0.000554	CcSEcCtD
Tolcapone—Nausea—Doxorubicin—bone cancer	0.000524	0.000526	CcSEcCtD
